日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Revealing How Acid Sites Enhance the Electrocatalytic Glycerol Oxidation Performance on Pt Loaded Zeolite-Carbon Composite Materials

揭示酸性位点如何增强铂负载沸石-碳复合材料的电催化甘油氧化性能

Kim, Ju Ye; No, Sunjae; Hwang, Jinwoo; Yoo, Mi; Lee, Hakju; Kim, Youngbi; Kim, Youngmin; Kim, Yong Tae; Kim, Jeong-Chul; Han, Jeong Woo; Kim, Kyoungsoo; Kim, Hyung Ju

Population pharmacokinetics and exposure-response analysis of durvalumab in patients with resectable stage II to IIIB (N2) NSCLC in the phase III AEGEAN study

在 III 期 AEGEAN 研究中,对可切除的 II 期至 IIIB 期 (N2) 非小细胞肺癌 (NSCLC) 患者进行度伐利尤单抗的群体药代动力学和暴露-反应分析

Zhao, Xiaoying; Ding, Junjie; Zhao, Jiajia; Zhang, Ling; Abegesah, Aburough; Zhang, Yu-Qian; O'Brien, Cathy; Doherty, Gary J; Chen, Allen C; Lim, KyoungSoo; Ren, Song; Ma, Peiming; Zhou, Diansong

Optimal Dosage Justification for Datopotamab Deruxtecan in HR-Positive/HER2-Negative Breast Cancer Through Model-Informed Drug Development Approaches

通过模型指导的药物开发方法,确定达托泊单抗德鲁西替康在HR阳性/HER2阴性乳腺癌中的最佳剂量

Tang, Zoey; Lim, KyoungSoo; Jiang, Yu; Dai, David; Munegowda, Manjunatha; Khan, Sabrina; Xu, Lu; Shi, Lei; Pan, Yuzhuo; Hong, Ying; Ren, Song; Vajjah, Pavan; Gibbs, Megan; Zhou, Diansong

Exposure-Response Analyses of Datopotamab Deruxtecan (Dato-DXd) in Patients with Hormone Receptor (HR) Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer

达托泊单抗德鲁替康(Dato-DXd)在激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性乳腺癌患者中的暴露-反应分析

Tang, Zoey; Lim, KyoungSoo; Jiang, Yu; Denduluri, Neelima; Rokutanda, Nana; Pan, Yuzhuo; Hong, Ying; Ren, Song; Vajjah, Pavan; Zhou, Diansong

Insights into Mechanochemical Solid-State Ball-Milling Reaction: Monitoring Transition from Heterogeneous to Homogeneous Conditions

深入研究机械化学固态球磨反应:监测从非均相到均相条件的转变

Go, Eun Sul; Hong, Eun Ji; Lee, Ji Yeong; Stolar, Tomislav; Peterson, Gregory I; Emmerling, Franziska L; Kim, Kyoungsoo; Kim, Jeung Gon

Population pharmacokinetics and exposure-response analysis of durvalumab in combination with gemcitabine and cisplatin in patients with advanced biliary tract cancer

度伐利尤单抗联合吉西他滨和顺铂治疗晚期胆道癌患者的群体药代动力学和暴露-反应分析

Abegesah, Aburough; Oh, Do-Youn; Lim, KyoungSoo; Fan, Chunling; Chen, Cecil; Kim, Chong; Wang, Julie; Xynos, Ioannis; Zotkiewicz, Magdalena; Ren, Song; Phipps, Alex; Gibbs, Megan; Zhou, Diansong

Review of Qualitative Research Methods in Health Information System Studies

卫生信息系统研究中定性研究方法的回顾

Park, Kyoungsoo; Moon, Woojong

Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma

不可切除肝细胞癌患者接受曲美利单抗单药治疗或联合度伐利尤单抗治疗的暴露-反应分析

Song, Xuyang; Kelley, Robin Kate; Khan, Anis A; Standifer, Nathan; Zhou, Diansong; Lim, KyoungSoo; Krishna, Rajesh; Liu, Lu; Wang, Kun; McCoon, Patricia; Negro, Alejandra; He, Philip; Gibbs, Megan; Kurland, John F; Abou-Alfa, Ghassan K

A Consideration of Fixed Dosing Versus Body Size-Based Dosing Strategies for Chimeric Antigen Receptor T-Cell Therapies

嵌合抗原受体T细胞疗法中固定剂量与基于体型的给药策略的比较研究

He, Jimmy Zhijian; Wang, Hechuan; Lim, KyoungSoo; Ren, Song; Rollins, Fred; Vallaster, Markus; Wong, Ryan; Stebbings, Richard; Standifer, Nathan; Keefe, Robert; Phipps, Alex; Gibbs, Megan

Oligonucleotide-Based Reusable Electrochemical Silver(I) Sensor and Its Optimization via Probe Packing Density

基于寡核苷酸的可重复使用电化学银(I)传感器及其通过探针堆积密度优化

Kim, Kyoungsoo; Bae, Je Hyun; Han, Donghoon